Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells

Stem Cells

Volumn 28, Issue 8, 2010, Pages 1303-1314

  Watanabe, Kazuhide ^a   Meyer, Matthew J ^a   Strizzi, Luigi ^a   Lee, Joseph M ^a   Gonzales, Monica ^a   Bianco, Caterina ^a   Nagaoka, Tadahiro ^a   Farid, Shahram S ^b   Margaryan, Naira ^a   Hendrix, Mary J C ^a   Vonderhaar, Barbara K ^a   Salomon, David S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cripto 1; Embryonal carcinoma; Nanog; Oct4; Pluripotent stem cells; Tumorigenicity

Indexed keywords

CELL SURFACE MARKER; CRIPTO 1; GLYCOPROTEIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE; CELL SUBPOPULATION; CELL SURFACE; CONTROLLED STUDY; DEREGULATION; DNA METHYLATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE; HUMAN; HUMAN CELL; HUMAN EMBRYO; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NEOPLASM; NONHUMAN; PLURIPOTENT STEM CELL; PROMOTER REGION; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; EMBRYONAL CARCINOMA STEM CELLS; EPIDERMAL GROWTH FACTOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955797121     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.463     Document Type: Article

References (47)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science (New York, NY) 1998;282:1145-1147.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
3. Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev 2008;9:725-729.
4. Wong DJ, Liu H, Ridky TW et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008;2:333-344. (Pubitemid 351455242)
5. Ben-Porath I, Thomson MW, Carey VJ et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507. (Pubitemid 351601215)
6. Pal R, Ravindran G. Assessment of pluripotency and multilineage differentiation potential of NTERA-2 cells as a model for studying human embryonic stem cells. Cell Prolif 2006;39:585-598.
7. Andrews PW, Matin MM, Bahrami AR et al. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 2005;33:1526-1530.
8. Newman MB, Misiuta I, Willing AE et al. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev 2005;14:29-43. (Pubitemid 40328246)
9. Salomon DS, Bianco C, Ebert AD et al. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer 2000;7:199-226.
10. Watanabe K, Bianco C, Strizzi L et al. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration. J Biol Chem 2007;282:31643-31655.
11. Watanabe K, Hamada S, Bianco C et al. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor. J Biol Chem 2007;282:35772-35786.
12. Bianco C, Strizzi L, Normanno N et al. Cripto-1: an oncofetal gene with many faces. Curr Top Dev Biol 2005;67:85-133. (Pubitemid 43631284)
13. Ciccodicola A, Dono R, Obici S et al. Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 1989;8:1987-1991.
14. Assou S, Le Carrour T, Tondeur S et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells (Dayton, Ohio) 2007;25:961-973.
15. Hamada S, Watanabe K, Hirota M et al. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. Biochem Biophys Res Commun 2007;355:240-244.
16. Parish CL, Parisi S, Persico MG et al. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. Stem Cells (Dayton, Ohio) 2005;23:471-476. (Pubitemid 40478485)
17. Mancino M, Strizzi L, Wechselberger C et al. Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells. J Cell Physiol 2008;215:192-203.
18. Mancino M, Esposito C, Watanabe K et al. Neuronal guidance protein Netrin-1 induces differentiation in human embryonal carcinoma cells. Cancer Res 2009;69:1717-1721.
19. Strizzi L, Mancino M, Bianco C et al. Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland. J Cell Physiol 2008;216:824-834.
20. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.
21. Freemantle SJ, Kerley JS, Olsen SL et al. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 2002;21:2880-2889.
22. Farthing CR, Ficz G, Ng RK et al. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet 2008;4:e1000116.
23. Meissner A, Mikkelsen TS, Gu H et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008;454:766-770.
24. Oulad-Abdelghani M, Chazaud C, Bouillet P et al. Stra3/lefty, a retinoic acid-inducible novel member of the transforming growth factor-beta superfamily. Int J Dev Biol 1998;42:23-32. (Pubitemid 28088189)
25. Baldassarre G, Romano A, Armenante F et al. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 1997;15:927-936.
26. Singh AM, Hamazaki T, Hankowski KE et al. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells (Dayton, Ohio) 2007;25:2534-2542.
27. Tanaka TS. Transcriptional heterogeneity in mouse embryonic stem cells. Reprod Fertil Dev 2009;21:67-75.
28. Graf T, Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell 2008;3:480-483.
29. Hayashi K, Lopes SM, Tang F et al. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. Cell Stem Cell 2008;3:391-401.
30. Parisi S, D'Andrea D, Lago CT et al. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol 2003;163:303-314. (Pubitemid 37363131)
31. Chou YF, Chen HH, Eijpe M et al. The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell 2008;135:449-461.
32. Loh YH, Wu Q, Chew JL et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-440.
33. Kim J, Chu J, Shen X et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008;132:1049-1061.
34. Chen X, Xu H, Yuan P et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008;133:1106-1117.
35. He Z, Jiang J, Kokkinaki M et al. Nodal signaling via an autocrine pathway promotes proliferation of mouse spermatogonial stem/progenitor cells through Smad2/3 and Oct-4 activation. Stem Cells (Dayton, Ohio) 2009;27:2580-2590.
36. Xu RH, Sampsell-Barron TL, Gu F et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 2008;3:196-206.
37. Ogawa K, Saito A, Matsui H et al. Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells. J Cell Sci 2007;120:55-65.
38. Vallier L, Alexander M, Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005;118:4495-4509. (Pubitemid 41556347)
39. Brons IG, Smithers LE, Trotter MW et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007;448:191-195.
40. Gidekel S, Pizov G, Bergman Y et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003;4:361-370.
41. Hochedlinger K, Yamada Y, Beard C et al. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005;121:465-477. (Pubitemid 40692305)
42. Chang CC, Shieh GS, Wu P et al. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 2008;68:6281-6291.
43. Hu T, Liu S, Breiter DR et al. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 2008;68:6533-6540.
44. Jeter CR, Badeaux M, Choy G et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (Dayton, Ohio) 2009;27:993-1005.
45. Cocciadiferro L, Miceli V, Kang KS et al. Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. Ann NY Acad Sci 2009;1155:257-262.
46. Strizzi L, Abbott DE, Salomon DS et al. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle (Georgetown, TX) 2008;7:1931-1935.
47. Adkins HB, Bianco C, Schiffer SG et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 2003;112:575-587.